Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-07-30Clinical Trial Update: Study to Evaluate the Safety and Efficacy of Pomalidomide Monotherapy in Subjects With Refractory or Relapsed Refractory Multiple Myeloma [Phase 3]
Phase 3 trial evaluating pomalidomide monotherapy in refractory/relapsed multiple myeloma has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2015-07-29Clinical Trial Update: Aflibercept for Relapsed Multiple Myeloma [Phase 2]
Phase 2 trial update of aflibercept for relapsed multiple myeloma; study terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2015-07-28Clinical Trial Update: Study of Thrombin Generation During the 3 First Cycles of Chemotherapy in Patients With Newly Diagnosed Multiple Myeloma
This clinical trial update describes thrombin generation during the first three cycles of chemotherapy in patients with newly diagnosed mult…
-
CLINICAL_TRIALS trial_result · 2015-07-28Clinical Trial Update: Phase 1 Study of CC-486 in Japanese Subjects With Hematological Neoplasms [Phase 1]
Termination of a Phase 1 trial evaluating oral azacitidine (CC-486) in Japanese subjects with hematological neoplasms.
-
CLINICAL_TRIALS trial_result · 2015-07-24Clinical Trial Update: Lenalidomide and Vaccine Therapy in Treating Patients With Relapsed or Refractory Multiple Myeloma [Phase 2]
Phase 2 trial of lenalidomide in combination with vaccine therapy for relapsed or refractory multiple myeloma has completed, with results po…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-07-23Clinical Trial Update: Lenalidomide After Reduced-intensity Allogeneic Stem Cell Transplantation for Relapsed Multiple Myeloma [Phase 1]
This clinical trial update reports on a Phase 1 study of lenalidomide after reduced-intensity allogeneic stem cell transplantation in relaps…
-
CLINICAL_TRIALS trial_result · 2015-07-23Clinical Trial Update: Comparative Trial of Cryotherapy Versus Caphosol Versus Saline Solution Mouth Washes for the Prevention of Oral Mucositis in Patients With Multiple Myeloma Undergoing Hematopoietic Stem Cell Transplantation [NA]
A completed randomized trial compared cryotherapy, Caphosol (calcium phosphate rinse), and saline mouth wash for the prevention of oral muco…
-
CLINICAL_TRIALS trial_result · 2015-07-08Clinical Trial Update: Clinical Trial of PXD101 in Patients With Advanced Multiple Myeloma [Phase 2]
This document reports the completion of a Phase 2 clinical trial evaluating belinostat (PXD101) in patients with advanced multiple myeloma.
-
CLINICAL_TRIALS trial_result · 2015-07-08Clinical Trial Update: Study Comparing Carfilzomib, Lenalidomide, and Dexamethasone (CRd) vs Lenalidomide and Dexamethasone (Rd) in Subjects With Relapsed Multiple Myeloma [Phase 3]
Phase 3 trial comparing carfilzomib plus lenalidomide and dexamethasone (CRd) versus lenalidomide and dexamethasone (Rd) in relapsed multipl…
-
CLINICAL_TRIALS trial_result · 2015-07-08Clinical Trial Update: A Phase II Study of Belinostat in Combination With Bortezomib in Patients With Relapsed, Refractory Multiple Myeloma [Phase 2]
A Phase II trial evaluating belinostat in combination with bortezomib for relapsed and refractory multiple myeloma has been terminated.
-
CLINICAL_TRIALS trial_result · 2015-07-07Clinical Trial Update: Multi-level Evaluation of Chemotherapy-induced Febrile Neutropenia Prophylaxis, Outcomes, and Determinants With Granulocyte-colony Stimulating Factor
A completed clinical trial evaluated granulocyte-colony stimulating factor (G-CSF) for prevention of chemotherapy-induced febrile neutropeni…
-
CLINICAL_TRIALS trial_result · 2015-06-30Clinical Trial Update: Observational Study to Evaluate the Efficacy and Safety of Bortezomib, Melphalan, Prednisone (VMP) in Participants With Multiple Myeloma
This completed observational study evaluates the efficacy and safety of the VMP regimen (bortezomib, melphalan, prednisone) in patients with…
-
CLINICAL_TRIALS trial_result · 2015-06-29Clinical Trial Update: Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma [Phase 3]
A Phase 3 trial assessing combinations of melphalan, prednisone, and thalidomide or lenalidomide for newly diagnosed multiple myeloma.
-
CLINICAL_TRIALS trial_result · 2015-06-29Clinical Trial Update: A Phase 1 Safety Study of LY2127399 in Combination With Bortezomib [Phase 1]
A completed Phase 1 safety study evaluating LY2127399 in combination with bortezomib for multiple myeloma.
-
CLINICAL_TRIALS trial_result · 2015-06-29Clinical Trial Update: Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma [Phase 3]
Phase 3 trial update evaluating melphalan, prednisone, and either thalidomide or lenalidomide in newly diagnosed multiple myeloma.
-
CLINICAL_TRIALS trial_result · 2015-06-26Clinical Trial Update: Bortezomib and Dexamethasone With or Without Lenalidomide in Treating Patients With Multiple Myeloma Previously Treated With Dexamethasone [Phase 3]
A Phase 3 trial evaluating bortezomib and dexamethasone with or without lenalidomide in patients with previously treated multiple myeloma wa…
-
CLINICAL_TRIALS trial_result · 2015-06-26Clinical Trial Update: Velcade, Thalidomide, Dexamethasone and Panobinostat Treatment and Panobinostat Maintenance in Multiple Myeloma [Phase 1, Phase 2]
Phase 1/Phase 2 clinical trial evaluating Velcade (bortezomib) with thalidomide and dexamethasone, and panobinostat with panobinostat mainte…
-
CLINICAL_TRIALS trial_result · 2015-06-24Clinical Trial Update: Combination Bisphosphonate and Anti-Angiogenesis Therapy With Pamidronate and Thalidomide [Phase 2]
Phase 2 trial evaluating the combination of pamidronate and thalidomide in multiple myeloma has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2015-06-22Clinical Trial Update: Study Evaluating the Tolerance and Biological Activity of Oral Clioquinol in Patients With Relapsed or Refractory Hematological Malignancy [Phase 1]
Phase 1 clinical trial evaluating the safety, tolerability, and biological activity of oral clioquinol in patients with relapsed or refracto…
-
CLINICAL_TRIALS trial_result · 2015-06-19Clinical Trial Update: Lenalidomide/Bortezomib/Dexamethasone & CNTO 328 in Transplant Eligible Newly Diagnosed Multiple Myeloma (MM) [Phase 1, Phase 2]
Phase 1/2 trial evaluating lenalidomide, bortezomib, and dexamethasone with CNTO 328 (siltuximab) in transplant-eligible newly diagnosed mul…
-
CLINICAL_TRIALS trial_result · 2015-06-11Clinical Trial Update: Abdominal CT to Predict the Risk of Acute Graft-versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation [EARLY_Phase 1]
An early-phase study update reporting completion of a trial using abdominal CT to predict acute graft-versus-host disease risk after allogen…
-
CLINICAL_TRIALS trial_result · 2015-06-11Clinical Trial Update: Rituximab and Cyclophosphamide in Treating Patients With High Risk, Refractory, or Relapsed Multiple Myeloma [Phase 2]
Phase 2 clinical trial evaluating the combination of rituximab and cyclophosphamide in patients with high-risk, refractory, or relapsed mult…
-
CLINICAL_TRIALS trial_result · 2015-06-10Clinical Trial Update: Liposomal Doxorubicin, Vincristine, & Dexamethasone Plus Arsenic Trioxide in Untreated Symptomatic Multiple Myeloma [Phase 2]
A Phase 2 clinical trial evaluating a combination of liposomal doxorubicin, vincristine, and dexamethasone plus arsenic trioxide in untreate…
-
CLINICAL_TRIALS trial_result · 2015-06-10Clinical Trial Update: The Effects of Huang-Lian-Jie-Du-Tang（HLJDT) on the Survival of Patients With Multiple Myeloma in Maintain Therapy [Phase 1]
A Phase 1 trial assessing the safety and potential impact of Huang-Lian-Jie-Du-Tang on survival in maintenance therapy for patients with mul…
-
CLINICAL_TRIALS trial_result · 2015-06-09Clinical Trial Update: Celecoxib in Preventing Multiple Myeloma in Patients With Monoclonal Gammopathy or Smoldering Myeloma [Phase 2]
A Phase 2 trial update on using celecoxib to prevent progression to multiple myeloma in patients with MGUS or smoldering myeloma; the study …